Phreesia Inc. (PHR)
NYSE
Closed
Aug 24, 2026
Day's Range
11.6952 wk Range
7.77Overview - PHR - Phreesia Inc.
Key Statistics
Valuation
Enterprise Value
767.01M
P/E (Trailing)
‪75.75‬
P/E (Forward)
‪7.54‬
PEG Ratio
‪-0.44‬
Price / Sales (TTM)
‪1.51‬
Price / Book
‪2.08‬
EV / EBITDA
‪23.36‬
Profitability
Gross Margin
‪66.90%‬
Profit Margin
‪1.85%‬
Operating Margin
‪5.15%‬
Return on Assets
‪1.48%‬
Return on Equity
‪2.86%‬
Ownership
Shares Outstanding
61.77M
Float
49.91M
Short % of Shares Outstanding
‪5.80%‬
Held by Insiders
‪4.37%‬
Held by Institutions
‪96.75%‬
Price stats
Beta
‪0.84‬
50-Day Avg
‪10.75‬
200-Day Avg
‪12.83‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Analyst Consensus
19 analysts
Average price target
‪$ 13.94‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PHR - Phreesia Inc.
Peers - PHR - Phreesia Inc.
Peer Comparison
Compared with companies in Health Information Services listed on NYSE.
Profile Summary - PHR - Phreesia Inc.
About
Phreesia Inc. is a healthcare technology company that provides patient intake and engagement solutions for medical practices. Its primary function is to streamline the patient registration and intake process through digital tools, enhancing both operational efficiency and patient experience. Phreesia's platform offers…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
